Literature DB >> 18936977

Localization of chondroitin sulfate proteoglycan versican in adult brain with special reference to large projection neurons.

Noriko Horii-Hayashi1, Hiroaki Okuda, Kouko Tatsumi, Shigeaki Ishizaka, Masahide Yoshikawa, Akio Wanaka.   

Abstract

Versican is a chondroitin sulfate proteoglycan belonging to the lectican family. Versican has two glycosaminoglycan attachment regions, named the GAG alpha and GAG beta domains, which are both regulated by alternative splicing and yield four protein isoforms. We have investigated the expression and localization of versican in the developing and adult brain by using anti-versican GAG alpha and GAG beta antibodies. Western analysis revealed that GAG alpha-reactive isoform was dominant in the adult brain. Immunohistochemical study demonstrated that GAG alpha immunoreactivity was detectable from neonatal periods to adulthood, whereas GAG beta immunoreactivity completely disappeared within 3 weeks of birth. In the adult brain, GAG alpha immunoreactivity was seen in the white matter regions and was also localized in the gray matter including somata and dendrites of cortical and hippocampal pyramidal neurons and cerebellar Purkinje cells. In contrast, GAG alpha immunoreactivity was not localized on parvalbumin-positive interneurons and cerebellar stellate cells. Furthermore, GAG alpha immunoreactivity was not co-localized with perineuronal net markers such as Wisteria floribunda agglutinin lectin and phosphacan. Thus, versican was localized on large projection neurons rather than small interneurons. To confirm the binding mechanism of versican to neurons, hyaluronan and chondroitin sulfates were enzymatically removed from brain sections before the immunolabeling of versican. These treatments had no effect on the labeling pattern of versican, suggesting that other versican-interactive molecules are involved in the binding of versican to neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936977     DOI: 10.1007/s00441-008-0698-1

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  8 in total

1.  Proteoglycans in Normal and Healing Skin.

Authors:  Margaret Mary Smith; James Melrose
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

2.  Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.

Authors:  Jae-Hyuk Yi; Yasuhiro Katagiri; Bala Susarla; David Figge; Aviva J Symes; Herbert M Geller
Journal:  J Comp Neurol       Date:  2012-10-15       Impact factor: 3.215

3.  Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.

Authors:  Susan M Smith; John M Whitelock; Renato V Iozzo; Christopher B Little; James Melrose
Journal:  Histochem Cell Biol       Date:  2009-08-11       Impact factor: 4.304

4.  Single-nucleus transcriptome analysis reveals cell-type-specific molecular signatures across reward circuitry in the human brain.

Authors:  Matthew N Tran; Kristen R Maynard; Abby Spangler; Louise A Huuki; Kelsey D Montgomery; Vijay Sadashivaiah; Madhavi Tippani; Brianna K Barry; Dana B Hancock; Stephanie C Hicks; Joel E Kleinman; Thomas M Hyde; Leonardo Collado-Torres; Andrew E Jaffe; Keri Martinowich
Journal:  Neuron       Date:  2021-09-27       Impact factor: 18.688

5.  Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry.

Authors:  Jessica M Snyder; Ida M Washington; Timothy Birkland; Mary Y Chang; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

6.  Developmental changes in desensitisation of c-Fos expression induced by repeated maternal separation in pre-weaned mice.

Authors:  N Horii-Hayashi; T Sasagawa; W Matsunaga; Y Matsusue; C Azuma; M Nishi
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

7.  Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia.

Authors:  Charmaine Y Pietersen; Sarah A Mauney; Susie S Kim; Maribel P Lim; Robert J Rooney; Jill M Goldstein; Tracey L Petryshen; Larry J Seidman; Martha E Shenton; Robert W McCarley; Kai-C Sonntag; Tsung-Ung W Woo
Journal:  J Neurogenet       Date:  2014-04-10       Impact factor: 1.250

8.  An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.

Authors:  Michael B Keough; James A Rogers; Ping Zhang; Samuel K Jensen; Erin L Stephenson; Tieyu Chen; Mitchel G Hurlbert; Lorraine W Lau; Khalil S Rawji; Jason R Plemel; Marcus Koch; Chang-Chun Ling; V Wee Yong
Journal:  Nat Commun       Date:  2016-04-26       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.